GlobeNewswire
Connect Biopharma Holdings Limited announces pricing of Initial Public Offering
SAN DIEGO and TAICANG, China, March 18, 2021 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T-cell-driven research, today announced the pricing of its initial public offering of 11,250,000…
Source link
